← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue increased 2.8% to $1.54B, while Net income increased 22.8% to ($285.9M).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $1.54BWatch
- Profitability — Net income ($285.9M)Watch
- Cash generation — Free cash flow N/ANote
- Accounting — No applicable forensic screenNote
- Insiders — 1 buys; 0 sells in 365 daysOK
- Capital — dividends paid were $9.7M; share repurchases were $1.1MNote
Business
DIVERSIFIED HEALTHCARE TRUST: Our Business Strategy The healthcare industry remains one of the most resilient commercial real estate sectors, in PART due to the scale of the U.S. healthcare market, which collectively represents approximately 18% of the U.S. gross domestic product, or GDP, according to the Centers for Medicare and Medicaid Services, or CMS.
Where the revenue comes from
Fiscal 2025, as DIVERSIFIED HEALTHCARE TRUST reports it. History and quarterly detail are in the app.
- SHOP$1.3B
- Medical Office and Life Science Portfolio$193.8M
Leadership changes
From DIVERSIFIED HEALTHCARE TRUST's own filings, the day they're filed.
- Alan L. Felder · Trustee · appointmenteff. 2025-03-20
- Christopher J. Bilotto · President · appointmenteff. 2024-01-01
- Office Properties Income Trust · departureeff. 2023-12-31
Latest filings
- 10-Q · Quarterly report2026-08-03
- 8-K · Company announcement2026-08-03
- 8-K · Company announcement2026-06-12
- 8-K · Company announcement2026-06-01
- 8-K · Company announcement2026-05-05
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about DIVERSIFIED HEALTHCARE TRUST, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.